News Headlines Article

Rule aims at averting drug shortages
Modern Healthcare

The Obama administration issued an interim final rule requiring drug companies that are the sole producer of certain critical drugs to report all product manufacturing interruptions to the Food and Drug Administration. Prior to the interim final rule, legal notification was required when production of a critical drug manufactured by only one company was being discontinued. The announcement follows an executive order issued by President Barack Obama on Oct. 31 that encourages manufacturers to voluntarily notify the FDA about potential prescription drug shortages.